Cameroon vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Access to anti-retroviral drugs, female
Access to anti-retroviral drugs, female over time
- Cameroon
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
How they compare
Cameroon currently reports 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 56.6%.
That makes Cameroon's figure about 2.5 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ahead.
Cameroon ranks 19th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th of 141 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 3.8% | 0.4% | Cameroon |
| 2010s | 38.0% | 20.3% | 17.7% | Cameroon |
| 2020s | 86.6% | 34.3% | 52.3% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cameroon or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Cameroon, at 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cameroon and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 56.6%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for access to anti-retroviral drugs, female?
- Cameroon ranks 19th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.